Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | Original Paper

Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea

Authors: Hyung Joon Yim, Kwan Soo Byun, Yun Jung Chang, Yeon Seok Suh, Jong Eun Yeon, Chang Hong Lee, Jung Ah Kwon, Wangdon Yoo, Soo-Ok Kim, Sun Pyo Hong

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

The levels of HBV replication in the nonreplicative phase are not clear. We conducted this study to evaluate the levels of viral replication during the nonreplicative phase in chronic HBV-infected Korean patients using real-time PCR. A total of 125 patients were classified into three groups: inactive HBsAg carriers, inactive liver cirrhosis patients, and resolved chronic HBV-infected patients with loss of HBsAg. The real-time PCR detected HBV DNA in 112 cases (89.6%). The mean levels of HBV DNA were 3.84, 4.10, and 3.31 log copies/ml in the three groups, respectively (P <0.01). Ninety-five percent of inactive HBsAg carriers showed levels of HBV DNA lower than 6×104 copies/ml. In conclusion, we showed different levels of HBV DNA exactly in three groups during nonreplicative phases. We suggest that the cutoff level of HBV DNA in inactive HBsAg carriers should be readjusted to a lower level in future studies.
Literature
1.
go back to reference Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC (1991) Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study. Hepatology 13:627–631PubMedCrossRef Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC (1991) Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study. Hepatology 13:627–631PubMedCrossRef
2.
go back to reference Papatheodoridis GV, Hadziyannis SJ (2001) Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 8:311–321PubMedCrossRef Papatheodoridis GV, Hadziyannis SJ (2001) Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 8:311–321PubMedCrossRef
4.
go back to reference Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ (2003) Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98:2261–2267PubMed Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ (2003) Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98:2261–2267PubMed
5.
go back to reference Song BC, Cui XJ, Kim H (2005) Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 48:133–137PubMedCrossRef Song BC, Cui XJ, Kim H (2005) Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 48:133–137PubMedCrossRef
6.
go back to reference Lee SH, Han SH, Cho SC, Roh BJ, Sohn JH, Kim DA, Lee DH, Kee CS (2001) Distribution of HBV genotypes in patients with chronic HBV infection in Korea. Korean J Hepatol 7:373–380 Lee SH, Han SH, Cho SC, Roh BJ, Sohn JH, Kim DA, Lee DH, Kee CS (2001) Distribution of HBV genotypes in patients with chronic HBV infection in Korea. Korean J Hepatol 7:373–380
7.
go back to reference Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef
8.
go back to reference Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 97:265–272PubMedCrossRef Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 97:265–272PubMedCrossRef
9.
go back to reference Chung HT, Lai CL, Lok AS (1995) Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 22:25–29PubMed Chung HT, Lai CL, Lok AS (1995) Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 22:25–29PubMed
10.
go back to reference Niesters HG (2001) Quantitation of viral load using real-time amplification techniques. Methods 25:419–429PubMedCrossRef Niesters HG (2001) Quantitation of viral load using real-time amplification techniques. Methods 25:419–429PubMedCrossRef
11.
go back to reference Nurmi J, Ylikoski A, Soukka T, Karp M, Lovgren T (2000) A new label technology for the detection of specific polymerase chain reaction products in a closed tube. Nucleic Acids Res 28:e28PubMedCrossRef Nurmi J, Ylikoski A, Soukka T, Karp M, Lovgren T (2000) A new label technology for the detection of specific polymerase chain reaction products in a closed tube. Nucleic Acids Res 28:e28PubMedCrossRef
12.
go back to reference Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K (1983) The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 11:1747–1757PubMedCrossRef Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K (1983) The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 11:1747–1757PubMedCrossRef
13.
go back to reference Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A, WHO Collaborative Study Group (2001) An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80:63–71PubMedCrossRef Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A, WHO Collaborative Study Group (2001) An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80:63–71PubMedCrossRef
14.
go back to reference Yao JD, Beld MG, Oon LL, Sherlock CH, Germer J, Menting S, Se Thoe SY, Merrick L, Ziermann R, Surtihadi J, Hnatyszyn HJ (2004) Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol 42:800–806PubMedCrossRef Yao JD, Beld MG, Oon LL, Sherlock CH, Germer J, Menting S, Se Thoe SY, Merrick L, Ziermann R, Surtihadi J, Hnatyszyn HJ (2004) Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol 42:800–806PubMedCrossRef
15.
go back to reference Pawlotsky JM (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39(Suppl 1):31–35CrossRef Pawlotsky JM (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39(Suppl 1):31–35CrossRef
16.
go back to reference Aliyu SH, Aliyu MH, Salihu HM, Parmar S, Jalal H, Curran MD (2004) Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system. J Clin Virol 30:191–195PubMedCrossRef Aliyu SH, Aliyu MH, Salihu HM, Parmar S, Jalal H, Curran MD (2004) Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system. J Clin Virol 30:191–195PubMedCrossRef
17.
go back to reference Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P (2002) Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36:543–546PubMedCrossRef Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P (2002) Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36:543–546PubMedCrossRef
18.
go back to reference Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL (2004) HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects. Hepatology 39:1694–1701PubMedCrossRef Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL (2004) HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects. Hepatology 39:1694–1701PubMedCrossRef
19.
go back to reference Chen YC, Sheen IS, Chu CM, Liaw YF (2002) Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123:1084–1089PubMedCrossRef Chen YC, Sheen IS, Chu CM, Liaw YF (2002) Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123:1084–1089PubMedCrossRef
20.
go back to reference Fattovich G (2003) Natural history of hepatitis B. J Hepatol 39(Suppl 1):50–58CrossRef Fattovich G (2003) Natural history of hepatitis B. J Hepatol 39(Suppl 1):50–58CrossRef
21.
go back to reference Chu CM, Liaw YF (1997) Natural history of chronic hepatitis B virus infection: An immunopathological study. J Gastroenterol Hepatol 12(Suppl):S218–S222PubMed Chu CM, Liaw YF (1997) Natural history of chronic hepatitis B virus infection: An immunopathological study. J Gastroenterol Hepatol 12(Suppl):S218–S222PubMed
22.
go back to reference Chu CM (2000) Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 15(Suppl):E25–E30PubMedCrossRef Chu CM (2000) Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 15(Suppl):E25–E30PubMedCrossRef
23.
go back to reference de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G (1993) The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191–194PubMed de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G (1993) The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191–194PubMed
24.
go back to reference Lindh M, Horal P, Dhillon AP, Norkrans G (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 7:258–267PubMedCrossRef Lindh M, Horal P, Dhillon AP, Norkrans G (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 7:258–267PubMedCrossRef
25.
go back to reference Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S (1997) Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27:251–258PubMedCrossRef Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S (1997) Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27:251–258PubMedCrossRef
26.
go back to reference Gandhi MJ, Yang GG, McMahon B, Vyas G (2000) Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia in surface antigen negative/antibody-positive carriers by polymerase chain reaction. Transfusion 40:910–916PubMedCrossRef Gandhi MJ, Yang GG, McMahon B, Vyas G (2000) Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia in surface antigen negative/antibody-positive carriers by polymerase chain reaction. Transfusion 40:910–916PubMedCrossRef
27.
go back to reference Mukaide M, Tanaka Y, Katayose S, Tano H, Murata M, Hikata M, Fujise K, Sakugawa H, Suzuki K, Zaunders J, Nagasawa Y, Toda G, Mizokami M (2003) Development of real-time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard. J Gastroenterol Hepatol 18:1264–1271PubMedCrossRef Mukaide M, Tanaka Y, Katayose S, Tano H, Murata M, Hikata M, Fujise K, Sakugawa H, Suzuki K, Zaunders J, Nagasawa Y, Toda G, Mizokami M (2003) Development of real-time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard. J Gastroenterol Hepatol 18:1264–1271PubMedCrossRef
28.
go back to reference Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD (1998) Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231–236PubMedCrossRef Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD (1998) Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231–236PubMedCrossRef
29.
go back to reference Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356–1371PubMedCrossRef Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356–1371PubMedCrossRef
30.
go back to reference Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K (2003) High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41:5449–5455PubMedCrossRef Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K (2003) High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41:5449–5455PubMedCrossRef
Metadata
Title
Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea
Authors
Hyung Joon Yim
Kwan Soo Byun
Yun Jung Chang
Yeon Seok Suh
Jong Eun Yeon
Chang Hong Lee
Jung Ah Kwon
Wangdon Yoo
Soo-Ok Kim
Sun Pyo Hong
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9140-2

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.